In Vitro Diagnostics (IVD) Quality Control Products Market Report, published by Allied Market Research, forecasts that the global market was valued at $823 million in 2015, and is expected to reach $1,052 million by 2022, registering a CAGR of 3.5% during the forecast period 2016 - 2022. The quality controls products segment dominated the market with fourth-fifths share in 2015. Immunochemistry and clinical chemistry application segments together captured around half of the market share in 2015.

The IVD quality control products market is driven by factors such as increasing number of accredited laboratories, stringent mandates on the use of third party IVD quality control products, and increase in the number of IVD test volumes across the globe.

Increase in adoption of multianalyte controls and focus of key players on expanding their market presence in emerging economies are anticipated to create new growth opportunities for market players. However, poor reimbursement scenario and lack of regulations regarding the use of controls in emerging economies are expected to hamper the market growth during the analysis period.

North America was the highest revenue contributor to the global market. Asia-Pacific is projected to be the fastest-growing region by 2022, registering a CAGR of 4.9% during the forecast period, due to increase in acceptance of third party IVD control products and spiraling number of accredited laboratories in the region.

Download Sample PDF Brochure at: https://www.alliedmarketresearch.com/request-sample/1792

The key players in the IVD quality control products market have focused on expanding their business operations in the emerging economies by adopting strategies such as new product launches and geographical expansion. The major market players profiled in the report include Abbott Diagnostics, Bio-Rad Laboratories, Inc., Roche Diagnostics, Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Helena Laboratories, Seracare Life Sciences, Inc., Technopath Clinical Diagnostics, and Sun Diagnostics, LLC.

In 2015, the quality controls segment accounted for the largest market share in the global market due to the upsurge in demand for third-party quality controls. The serum/plasma based controls accounted for the largest share in the quality controls market in 2015, and is estimated to grow at the fastest CAGR of 4.1% from 2016 to 2022, owing to the increase in demand for products with long self-life and high stability.

The immunochemistry application segment dominated the global market by application in 2015, owing to the rise in demand for high-sensitivity immunochemistry tests and increase in availability of multianalyte controls to test the accuracy of large immunoassay test menus.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1792

Author's Bio: 

I am Srushti . My keen interest in reading and writing. I forayed into the field of writing due to my love for words and the urge to do something different. I have been a part of the content resource team here in Allied Market Research. We have a dedicated team for content development wherein, we coordinate with the Market Analysts and create a precise content. I am personally involved in writing content for user engagement. I owe a responsibility to make sure the content is rich and user-centric. Allied Market Research has given me the chance to gain knowledge about different subjects.